Physician profile
Thomas P Mathew
NPI 1245282136
$20,719.70
in general payments reported to CMS, 2019-2025
57 companies · $3,152 in 2025
The $3,152 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,014 · 2020: $983 · 2021: $2,117 · 2022: $3,353 · 2023: $3,242 · 2024: $4,859 · 2025: $3,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $882 · Education: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,155.73 |
| Travel and Lodging | $882.18 |
| Education | $215.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,455.30 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,848.39 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $1,793.67 | 2019-2025 | Repatha, Evenity, Prolia |
| Medtronic, INC. | $1,671.04 | 2022-2024 | Minimed 780g |
| Abbott Laboratories | $1,156.69 | 2019-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $1,042.37 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $904.14 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $890.22 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $734.10 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $714.55 | 2019-2025 | Xifaxan, Trulance, Cycloset |
| Novartis Pharmaceuticals Corporation | $704.61 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $608.55 | 2019-2024 | Xarelto |
| Astellas Pharma US INC | $606.35 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $586.07 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $561.54 | 2021-2025 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $428.36 | 2021-2025 | Unithroid |
| Exact Sciences Corporation | $425.62 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $323.55 | 2019-2025 | |
| Horizon Therapeutics Plc | $308.33 | 2019-2023 | Tepezza |
| Dexcom, INC. | $298.57 | 2021 | |
| Merck Sharp & Dohme LLC | $283.87 | 2019-2024 | Capvaxive |
| Amarin Pharma, INC. | $279.30 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $259.65 | 2021-2025 | Gvoke Hypopen |
| Cequr Corporation | $245.56 | 2023-2025 | Cequr Simplicity |
| Insulet Corporation | $221.59 | 2019-2020 | |
| Intuity Medical INC | $192.46 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Kowa Pharmaceuticals America, INC. | $138.38 | 2019-2021 | |
| Esperion Therapeutics, INC. | $107.63 | 2021-2025 | Nexletol |
| Hikma Pharmaceuticals USA | $67.13 | 2019-2020 | |
| Corcept Therapeutics | $64.91 | 2023-2024 | Korlym |
| Sumitomo Pharma America, INC. | $61.75 | 2024-2025 | Gemtesa, Myfembree |
| Althera Pharmaceuticals LLC | $60.33 | 2021-2022 | |
| Eisai INC. | $56.71 | 2024-2025 | |
| Renalytix Ai, INC. | $46.14 | 2023-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Daiichi Sankyo INC. | $44.69 | 2019-2022 | |
| Shield Therapeutics INC | $43.70 | 2023 | Accrufer |
| Ironwood Pharmaceuticals, INC | $43.59 | 2019-2021 | |
| Mannkind Corporation | $35.13 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $34.28 | 2019 | |
| Edwards Lifesciences Corporation | $32.25 | 2022 | |
| Genentech USA, INC. | $28.33 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $25.87 | 2024 | Voquezna |
| Ultragenyx Pharmaceutical INC. | $24.51 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $23.72 | 2019 | |
| Scpharmaceuticals INC. | $22.64 | 2025 | |
| Vifor Pharma, INC. | $21.62 | 2022 | |
| Verona Pharma, INC. | $21.43 | 2025 | Ohtuvayre |
| Intra-Sana Laboratories | $20.13 | 2022 | |
| Avvisto Therapeutics, LLC | $20.00 | 2024 | Cycloset |
| Phadia US INC. | $19.72 | 2023 | Immunocap |
| Scilex Pharmaceuticals INC. | $19.40 | 2023 | Ztlido |
| Philips North America LLC | $18.44 | 2021 | |
| Corium, LLC | $16.09 | 2022 | |
| Alfasigma USA, INC. | $15.37 | 2021 | |
| Ionis Pharmaceuticals, INC. | $15.22 | 2025 | Tryngolza |
| Seqirus USA INC | $14.10 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.